Gentris to Enter IVD Market with Warfarin Dx As Shops Await FDA s Relabeling Decision

Gentris hopes to start clinical trials for the 2C9 test late this year, but doesn t expect the product, which, if cleared, would be its first in vitro diagnostic, to launch until at least 2007. Subscribers: click headline for more

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.